← Back to Search

Hormone Therapy

Vaginal Estrogen for Urinary Tract Infections (TAPER Trial)

Phase 2
Recruiting
Led By Stephanie W Zuo, MD
Research Sponsored by Stephanie Wang Zuo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meets criteria for recurrent urinary tract infections (UTIs) with 2 or more UTI in 6 months or 3 or more UTI in 1 year
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

TAPER Trial Summary

This trial aimed to compare the two methods of vaginal estrogen application.

Who is the study for?
This trial is for postmenopausal women who've had at least 2 UTIs in the last 6 months or 3 in a year, and are recommended vaginal estrogen to prevent more UTIs. They shouldn't be currently using any estrogen products, have significant vaginal narrowing, bladder stones, risk of estrogen-dependent cancer, or conditions preventing them from applying the cream themselves.Check my eligibility
What is being tested?
The study compares two ways of using estradiol cream to prevent recurrent urinary tract infections: periurethral (around the urethra) versus intravaginal application. It aims to determine if applying less cream around the urethra is as effective as the standard intravaginal method.See study design
What are the potential side effects?
While not explicitly listed here, typical side effects of topical estradiol may include local irritation or itching, increased chance of developing a rash or infection at the site of application.

TAPER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had 2 or more UTIs in 6 months or 3 or more in a year.

TAPER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of participants who are UTI-free at 6 months
Secondary outcome measures
Amount of estrogen cream used
Change from baseline in Vaginal and urinary E. coli levels at 6 months
Change from baseline in Vaginal and urinary Lactobacillus levels at 6 months
+6 more

TAPER Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Periurethral Estrogen ApplicationExperimental Treatment1 Intervention
Periurethral application of 0.5 gram estradiol cream at bedtime twice a week for 6 months
Group II: Intravaginal Estrogen ApplicationActive Control1 Intervention
Intravaginal application of 1 gram estradiol cream at bedtime twice a week for 6 months

Find a Location

Who is running the clinical trial?

Stephanie Wang ZuoLead Sponsor
Stephanie W Zuo, MDPrincipal InvestigatorUniversity of Pittsburgh Medical Center

Media Library

Estradiol Cream (Hormone Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05472779 — Phase 2
Urinary Tract Infection Research Study Groups: Intravaginal Estrogen Application, Periurethral Estrogen Application
Urinary Tract Infection Clinical Trial 2023: Estradiol Cream Highlights & Side Effects. Trial Name: NCT05472779 — Phase 2
Estradiol Cream (Hormone Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05472779 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can estradiol cream be applied near the urethra?

"Although there is some evidence of safety, as this is only a Phase 2 trial, the Power team rates the Periurethral application of estradiol cream at a 2."

Answered by AI

When will this experiment be open to new participants?

"As specified on clinicaltrials.gov, this research is not currently looking for participants. The trial was first posted on October 1st, 2020 and updated most recently on July 21st, 2020. Although this study isn't recruiting right now, there are plenty of other medical trials that are still searching for patients."

Answered by AI
~24 spots leftby Jul 2024